Literature DB >> 27015752

Clinical outcome of conventional versus biological fixation of subtrochanteric fractures by proximal femoral locked plate.

Ihab I El-Desouky1, Molham M Mohamed2, Ahmed E Kandil3.   

Abstract

INTRODUCTION: Surgical fixation is the standard management of the subtrochanteric fractures. Proximal femoral locked plating (PF-LCP) provides a strong construct for fixation with a high success rate. However, some studies reported implant failure due to loss of the postero-medial bone support and recommended an anatomical reduction. Other studies reported excellent to good results with indirect (biological) fixation without anatomical reduction. In this study, we reviewed the short-term clinical results of PF-LCP fixation for subtrochanteric fractures using both conventional and biological fixation.
MATERIALS AND METHODS: Forty six patients (34 males and 12 females) with comminuted subtrochanteric fractures were included aged between 18 and 74 (mean 44.3 years). They were treated in a single-blind random manner by either conventional (open, direct) or biological (indirect) reduction method and internal fixation with PF-LCP. Intra-operative variables including; duration of surgery, blood loss, fluoroscopy time and any complications were recorded. Post-operative differences including; duration of healing, implant failure, complications and the final clinical outcome by Harris Hip Score (HHS) were documented.
RESULTS: 44 cases continued to the final follow-up (23 of the open fixation group and 21 of the biological fixation group). Patients of open group demonstrated greater blood loss (756±151 vs. 260±39ml; P<0.0001), longer operative times (129±16.9 vs. 91±8min; P<0.0001) and incisions (s) length (20.4±3 vs. 13.4±1cm; P<0.0001). More patients needed blood transfusion in open group (11 patients vs. six in closed group; P<0.0001). Patients of biological group demonstrated longer fluoroscopy time (80.9±7.3 vs. 47.2±5.8sec.; P<0.0001). For each group, one case of implant failure was recorded. Low patient compliance was a detrimental factor for the implant failure in both cases. No much difference was demonstrated for the healing rate (open group; 18.3±3.7 vs. biological group16.5±4 weeks; P<0.058) and for the functional outcome (open group; excellent/good: 54%/37%, biological group; excellent/good: 57%/33%; P=0.766).
CONCLUSION: PF-LCP provided a strong construct for fixation of the comminuted subtrochanteric fractures either by open or biological techniques. Low patient compliance is an influential factor for implant failure in both types.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PF-LCP; Patient compliance; Proximal femoral plate; Subtrochanteric fractures

Mesh:

Year:  2016        PMID: 27015752     DOI: 10.1016/j.injury.2016.03.016

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Acute Femoral Lengthening in Adults Using Step-Cut Osteotomy, Traction Table, and Proximal Femoral Locking Plate Fixation: Surgical Technique and Report of Three Cases.

Authors:  Peter Brumat; Rene Mihalič; Simon Kovač; Rihard Trebše
Journal:  Indian J Orthop       Date:  2021-10-27       Impact factor: 1.251

Review 2.  Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.

Authors:  Sharon R Lewis; Richard Macey; Joseph Lewis; Jamie Stokes; James R Gill; Jonathan A Cook; William Gp Eardley; Martyn J Parker; Xavier L Griffin
Journal:  Cochrane Database Syst Rev       Date:  2022-02-10

3.  Reverse Less Invasive Stabilization System (LISS) Plating for Proximal Femur Fractures in Poliomyelitis Survivors: A Report of Two Cases.

Authors:  Chen Yao; Dongxu Jin; Changqing Zhang
Journal:  Am J Case Rep       Date:  2017-11-15

Review 4.  The biology and treatment of acute long-bones diaphyseal fractures: Overview of the current options for bone healing enhancement.

Authors:  Giuseppe Marongiu; Andrea Dolci; Marco Verona; Antonio Capone
Journal:  Bone Rep       Date:  2020-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.